Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Citations for PubMed (Select 18556571)

1.

Murine models of hyperhomocysteinemia and their vascular phenotypes.

Dayal S, Lentz SR.

Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1596-605. doi: 10.1161/ATVBAHA.108.166421. Epub 2008 Jun 12. Review.

2.

[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].

Guilland JC, Favier A, Potier de Courcy G, Galan P, Hercberg S.

Pathol Biol (Paris). 2003 Mar;51(2):101-10. Review. French.

PMID:
12801808
3.

The nutrigenetics of hyperhomocysteinemia: quantitative proteomics reveals differences in the methionine cycle enzymes of gene-induced versus diet-induced hyperhomocysteinemia.

DiBello PM, Dayal S, Kaveti S, Zhang D, Kinter M, Lentz SR, Jacobsen DW.

Mol Cell Proteomics. 2010 Mar;9(3):471-85. doi: 10.1074/mcp.M900406-MCP200. Epub 2009 Dec 14.

4.

Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.

Maclean KN, Jiang H, Greiner LS, Allen RH, Stabler SP.

Mol Genet Metab. 2012 Mar;105(3):395-403. doi: 10.1016/j.ymgme.2011.11.190. Epub 2011 Dec 2.

PMID:
22192524
5.

Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.

Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, Faraci FM.

Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H970-5.

6.

Mechanisms of thrombosis in hyperhomocysteinemia.

Lentz SR.

Curr Opin Hematol. 1998 Sep;5(5):343-9. Review.

PMID:
9776214
7.

Mechanisms of homocysteine-induced atherothrombosis.

Lentz SR.

J Thromb Haemost. 2005 Aug;3(8):1646-54. Review.

PMID:
16102030
8.

Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia.

Dayal S, Chauhan AK, Jensen M, Leo L, Lynch CM, Faraci FM, Kruger WD, Lentz SR.

Blood. 2012 Mar 29;119(13):3176-83. doi: 10.1182/blood-2011-09-380568. Epub 2011 Dec 20.

9.

Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.

Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR.

Circ Res. 2001 Jun 8;88(11):1203-9.

10.

Inhibition of betaine-homocysteine S-methyltransferase in rats causes hyperhomocysteinemia and reduces liver cystathionine β-synthase activity and methylation capacity.

Strakova J, Gupta S, Kruger WD, Dilger RN, Tryon K, Li L, Garrow TA.

Nutr Res. 2011 Jul;31(7):563-71. doi: 10.1016/j.nutres.2011.06.004.

11.

Homocysteine and atherothrombosis: diagnosis and treatment.

Handy DE, Loscalzo J.

Curr Atheroscler Rep. 2003 Jul;5(4):276-83. Review.

PMID:
12793968
12.

Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.

Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H816-25. doi: 10.1152/ajpheart.01348.2007. Epub 2008 Jun 20.

13.

Alterations of retinal vasculature in cystathionine-Beta-synthase mutant mice, a model of hyperhomocysteinemia.

Tawfik A, Al-Shabrawey M, Roon P, Sonne S, Covar JA, Matragoon S, Ganapathy PS, Atherton SS, El-Remessy A, Ganapathy V, Smith SB.

Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):939-49. doi: 10.1167/iovs.12-10536.

14.

Effects of betaine in a murine model of mild cystathionine-beta-synthase deficiency.

Schwahn BC, Wendel U, Lussier-Cacan S, Mar MH, Zeisel SH, Leclerc D, Castro C, Garrow TA, Rozen R.

Metabolism. 2004 May;53(5):594-9.

PMID:
15131763
15.

The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.

Jakubowski H.

J Physiol Pharmacol. 2008 Dec;59 Suppl 9:155-67. Review.

16.

Dietary intake of S-(alpha-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats.

Strakova J, Williams KT, Gupta S, Schalinske KL, Kruger WD, Rozen R, Jiracek J, Li L, Garrow TA.

Nutr Res. 2010 Jul;30(7):492-500. doi: 10.1016/j.nutres.2010.06.017.

17.

Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.

Dayal S, Lentz SR.

Antioxid Redox Signal. 2007 Nov;9(11):1899-909. Review.

PMID:
17822370
18.

Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.

Austin RC, Lentz SR, Werstuck GH.

Cell Death Differ. 2004 Jul;11 Suppl 1:S56-64. Review.

19.

Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice.

Wilson KM, McCaw RB, Leo L, Arning E, Lhoták S, Bottiglieri T, Austin RC, Lentz SR.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):233-40. Epub 2006 Nov 2.

20.

Hyperhomocysteinemia and thrombosis.

Lee R, Frenkel EP.

Hematol Oncol Clin North Am. 2003 Feb;17(1):85-102. Review.

PMID:
12627664
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk